Synopsis of recent research by authors named "Maxime Doiron"
- Maxime Doiron's research primarily focuses on the cognitive impairments associated with Parkinson's disease, particularly mild cognitive impairment (PD-MCI) and the influence of various factors such as medication and vascular risk factors on cognitive function.
- Through multiple studies, he has explored innovative interventions like Goal Management Training® (GMT) and its home-based application, along with the effects of smoking history and antiparkinson medications on cognitive decline in PD patients.
- Doiron's findings contribute to a better understanding of how vascular risk factors impact cognitive health in early Parkinson's disease, as well as proposing cognitive tools to enhance decision-making abilities in complex scenarios.
